Cosmetic cross-reference

Betulinic Acid

CAS 472-15-1

Betulinic Acid (CAS 472-15-1) is a Phase 1 pharmaceutical compound with 12 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
12
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
1
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Betulinic Acid
CAS Number
472-15-1
UNII
4G6A18707N
InChIKey
QGJZLNKBHJESQX-FZFNOLFKSA-N
ChEMBL ID
CHEMBL269277
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 1
Early-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL269277 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 12 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 21905.949345794394 nM 318 -
- GI50 8343.087142857143 nM 126 -
- EC50 14452.484596774195 nM 122 -
- IC50 12.635 ug.mL-1 26 -
- Potency 13066.744444444443 nM 23 -
- GI50 22.34764705882353 ug.mL-1 17 -
- MIC 281571.4285714286 nM 14 -
- MIC 89.375 ug.mL-1 8 -
- Kd 7080.5 nM 6 -
- Ki 10100 nM 3 -
- AC50 3667.25 nM 2 -
- IC50 403 molar ratio 1 -
SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
GPBA receptor
GPBAR1
Full agonist 5.980000019073486 pEC50 19911773
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Betulinic Acid used for in pharmaceutical contexts?

Betulinic Acid (CAS 472-15-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Betulinic Acid?

No adverse-event association or SIDER side-effect rows are rendered for Betulinic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Betulinic Acid also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Betulinic Acid with EU status "permitted".

What clinical phase is Betulinic Acid in?

Betulinic Acid is rendered with ChEMBL max phase 1.